Alliance provides one-stop biosafety testing service

Beckman Coulter Australia
Tuesday, 05 April, 2011

Beckman Coulter Genomics and Vitrology Ltd have announced a strategic partnership to offer customers a wide range of biosafety testing services. The alliance provides the biopharmaceutical industry with two inclusive sources for the full complement of molecular, in vitro and in vivo genomic services necessary for the identification, stabilisation and purification of biological products.

The alliance also provides customers with access to the next-generation sequencing technologies that are revolutionising biology. It is widely recognised that massively parallel sequencing technologies hold incredible promise for the study of DNA sequence variation in vaccines, cell banks and gene therapy products, and allow the use of an open-question approach for the safety characterisation of biologics.

Beckman Coulter Genomics provides Sanger and next-generation DNA sequencing, gene expression profiling, genotyping and biologics testing services. The collaboration between Beckman Coulter Genomics and Vitrology further expands and complements both companies’ extensive biologics testing services portfolios, which are available to clients worldwide.

Related News

Aus researchers recognised for synchrotron science

ANSTO has announced accolades for Professor Peter Lay and Dr Wei Kong Pang, in recognition of...

Dr Cathy Foley appointed Australia's next Chief Scientist

Renowned physicist Dr Cathy Foley AO has been appointed Australia's next Chief Scientist,...

2020 Prime Minister's Prizes for Science awarded

A team that was instrumental in the world-first detection of gravitational waves has won the 2020...

  • All content Copyright © 2020 Westwick-Farrow Pty Ltd